Provider review
SurpassMD review
By The Dose Brief Desk · Updated
Introductory and renewal prices are published separately. Longer supply terms reduce the monthly equivalent but need a full billing quote.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- 30-day offer $175 introductory / $219 renewal
- Tirzepatide
- 30-day offer $247 introductory / $309 renewal
- Availability
- Confirm product availability for your state.
- Treatment formats
- Compounded injections; a separate oral semaglutide offer is listed.
Longer-term equivalents differ. First-subscription discount requires its code; cancel at least 72 hours before billing.
Start with the renewal price
SurpassMD lists a 30-day semaglutide offer at $175 initially and $219 on renewal, and tirzepatide at $247 initially and $309 on renewal. Its discount code applies to the first subscription. The renewal amount is the more useful figure when planning ongoing care.
Longer plans change the comparison
The medication pages also quote three-, six- and twelve-month supply terms. At twelve months, the listed monthly equivalents are $114 introductory/$143 renewal for semaglutide and $177/$222 for tirzepatide. Confirm the full amount charged and shipment schedule: a monthly equivalent does not mean monthly billing.
What the bundle includes
The medication pages include clinical review, medication, support and shipping without a separate membership fee. They describe dose-flat prices, while other home copy suggests dose may affect cost. Ask which rule applies to the specific product and plan. Life Vitality LLC is the entity named behind SurpassMD.
Cancellation is not a refund promise
The policy requests 72 hours of notice before billing and generally limits refunds to medical disqualification. The separate oral semaglutide offer should be compared on its own formulation and renewal terms. Before committing, obtain the assigned pharmacy and prescribing organization rather than relying on general licensed-provider language.
What stands out
- Introductory and renewal amounts are separate
- Supply-term options are publicly listed
What to check
- Upfront billing needs confirmation
- Dose-pricing copy is not fully consistent
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.